We are live on
!
Find out more
IA
IAM Advisory Portfolio holdings
AUM
$513M
Turnover
21.24%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.5%
1 Year Est. Return
+32.24%
3 Year Est. Return
+74.52%
5 Year Est. Return
+82.26%
10 Year Est. Return
–
AUM
$450M
AUM Growth
+$5.33M
(+1.2%)
Cap. Flow
-$2.6M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
67.73%
Holding
115
New
13
Increased
47
Reduced
37
Closed
11
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Group Dividend Value ETF
CGDV
|
+$40.5M |
| 2 |
Capital Group Growth ETF
CGGR
|
+$12.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.48M |
| 4 |
Gilead Sciences
GILD
|
+$1.26M |
| 5 |
Leidos
LDOS
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
|
+$29.6M |
| 2 |
John Hancock Multifactor Large Cap ETF
JHML
|
+$12.9M |
| 3 |
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
|
+$12.4M |
| 4 |
Marsh
MRSH
|
+$1.78M |
| 5 |
Zoetis
ZTS
|
+$1.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.5% |
| 2 | Technology | 7.38% |
| 3 | Industrials | 4.64% |
| 4 | Healthcare | 4.28% |
| 5 | Communication Services | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
ProShares Ultra Gold
UGL
$728M
| $414K | 0.09% |
7,458
+149
| +2% | +$7.8K |
2025 Q1
3 quarters
|
|
77
State Street Materials Select Sector SPDR ETF
XLB
$7.99B
| $406K | 0.09% |
8,950
+36
| +0.4% | +$1.59K |
2021 Q3
17 quarters
|
|
78
Invesco Large Cap Growth ETF
PWB
$2.63B
| $390K | 0.09% |
3,065
| – | – |
2021 Q3
17 quarters
|
|
79
Invesco Aerospace & Defense ETF
PPA
$7.56B
| $376K | 0.08% |
2,400
| – | – |
2022 Q4
12 quarters
|
|
80
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $351K | 0.08% |
2,261
-9
| -0.4% | -$1.39K |
2022 Q4
12 quarters
|
|
81
Johnson & Johnson
JNJ
$610B
| $321K | 0.07% |
1,551
+24
| +2% | +$4.75K |
2021 Q3
17 quarters
|
|
82
AbbVie
ABBV
$501B
| $309K | 0.07% |
1,352
-127
| -9% | -$28.9K |
2023 Q3
9 quarters
|
|
83
Vanguard Dividend Appreciation ETF
VIG
$113B
| $292K | 0.06% |
+1,329
| New | +$290K |
2025 Q4
0 quarters
|
|
84
VanEck BDC Income ETF
BIZD
$1.46B
| $269K | 0.06% |
18,965
+812
| +4% | +$11.6K |
2024 Q4
4 quarters
|
|
85
Baker Hughes
BKR
$54B
| $260K | 0.06% |
5,719
-429
| -7% | -$20.3K |
2024 Q2
6 quarters
|
|
86
Altria Group
MO
$123B
| $258K | 0.06% |
4,473
+14
| +0.3% | +$845 |
2024 Q3
5 quarters
|
|
87
Grayscale Bitcoin Trust
GBTC
$12.3B
| $256K | 0.06% |
3,740
| – | – |
2024 Q4
4 quarters
|
|
88
RTX Corp
RTX
$252B
| $253K | 0.06% |
1,380
+30
| +2% | +$5.21K |
2025 Q3
1 quarter
|
|
89
GraniteShares Platinum Shares
PLTM
$176M
| $241K | 0.05% |
+12,200
| New | +$199K |
2025 Q4
0 quarters
|
|
90
Ecolab
ECL
$81.5B
| $240K | 0.05% |
913
-112
| -11% | -$29.8K |
2023 Q3
9 quarters
|
|
91
Chevron
CVX
$430B
| $238K | 0.05% |
1,561
+109
| +8% | +$16.6K |
2025 Q3
1 quarter
|
|
92
Procter & Gamble
PG
$365B
| $236K | 0.05% |
1,645
-53
| -3% | -$7.82K |
2022 Q4
12 quarters
|
|
93
Global X MSCI Greece ETF
GREK
$328M
| $228K | 0.05% |
3,466
| – | – |
2025 Q3
1 quarter
|
|
94
State Street SPDR S&P Biotech ETF
XBI
$9.9B
| $225K | 0.05% |
+1,845
| New | +$212K |
2025 Q4
0 quarters
|
|
95
iShares MSCI Canada ETF
EWC
$7.28B
| $218K | 0.05% |
4,036
+36
| +0.9% | +$1.86K |
2025 Q3
1 quarter
|
|
96
Global X Silver Miners ETF NEW
SIL
$4.17B
| $217K | 0.05% |
2,597
-1,067
| -29% | -$78.7K |
2025 Q3
1 quarter
|
|
97
Coca-Cola
KO
$396B
| $215K | 0.05% |
3,073
-108
| -3% | -$7.53K |
2023 Q3
9 quarters
|
|
98
Abbott
ABT
$181B
| $213K | 0.05% |
1,701
+15
| +0.9% | +$1.91K |
2024 Q3
5 quarters
|
|
99
Freeport-McMoran
FCX
$101B
| $210K | 0.05% |
+4,137
| New | +$179K |
2025 Q4
0 quarters
|
|
100
Vanguard S&P 500 ETF
VOO
$1.05T
| $208K | 0.05% |
+331
| New | +$206K |
2025 Q4
0 quarters
|
|
Similar funds
BHWA
ACA
RCM
BA
BHC
AWMG
FMC
NI
IAM Advisory's Q4 2025 Portfolio in Review
As of Q4 2025, IAM Advisory held 115 positions worth $450M, up 1.2% from $445M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
IAM Advisory's Q4 2025 filing shows 13 new, 47 increased, 37 reduced and 11 closed positions. Its largest new stake was Bristol-Myers Squibb: 30,763 shares worth $1.66M. The largest sale was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $29.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 79% a quarter earlier, followed by Technology and Industrials.
- IAM Advisory's largest Q4 2025 buy was Bristol-Myers Squibb: 30,763 shares worth $1.66M.
- IAM Advisory added most to Capital Group Dividend Value ETF in Q4 2025, an estimated $40.5M increase.
- IAM Advisory's biggest Q4 2025 reduction was ProShares S&P 500 Dividend Aristocrats ETF, cutting an estimated $29.6M.
- IAM Advisory fully exited Marsh in Q4 2025, selling an estimated $1.78M.
- IAM Advisory's ten largest holdings make up 68% of its $450M portfolio in Q4 2025.
- IAM Advisory opened 13 new positions and closed 11 in Q4 2025.
- IAM Advisory's portfolio value rose 1.2% quarter-over-quarter to $450M.
Based on IAM Advisory's 13F filing for Q4 2025, filed 7 Jan 2026.